Consolidated Balance Sheets (USD $)	Dec. 31, 2011	Dec. 31, 2010
ASSETS
Cash	$ 0	$ 0
Accounts receivable, net of allowances for doubtful accounts of $603,893 and $0, respectively	0	0
Research grant receivable	0	244,479
Subscription receivable	8,000	0
Inventories-net	117,800	253,042
Prepaid expenses and other current assets	32,375	140,081
Total current assets	158,175	637,602
Property and equipment, net	54,509	69,207
Other assets	16,621	46,621
TOTAL ASSETS	229,305	753,430
LIABILITIES AND STOCKHOLDERS' DEFICIT
Accounts payable	1,098,452	710,638
Accrued expenses	951,073	949,824
Due to officers	850,529	1,205,382
Other debt	1,211,863	305,000
Total current liabilities	4,111,917	3,170,844
Derivative Warrant Liability	28,833	109,500
COMMITMENTS AND CONTINGENCIES
Stockholders' deficit:
Common stock, $0.001 par value, 2,000,000,000 shares authorized; 321,027,909 shaers issued and 315,313,673 shares outstanding at December 31, 2011 and 280,091,899 shares issued and outstanding at December 31, 2010	321,027	280,092
Common shares issuable	139,834	0
Additional paid-in capital	29,659,199	27,039,801
Deferred compensation	0	(212,500)
Accumulated deficit	(34,031,505)	(29,634,307)
Total stockholders' deficit	(3,911,445)	(2,526,914)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 229,305	$ 753,430